Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis

Author： Hirst C.   Pace A.   Pickersgill T.   Jones R.   McLean B.   Zajicek J.   Scolding N.   Robertson N.  

Publisher： Springer Publishing Company

ISSN： 0340-5354

Source： Journal of Neurology, Vol.255, Iss.2, 2008-02, pp. : 231-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cardiac repolarization during fingolimod treatment in patients with relapsing–remitting multiple sclerosis

By  

Brain And Behavior, Vol. 8, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Differential response to treatment of relapsing–remitting multiple sclerosis with IFN-&bgr;: is there a dichotomy into T-helper-1 and -17 driven disease?

By Weissert Robert  

Future Neurology, Vol. 5, Iss. 4, 2010-07 ,pp. : 481-484

Future Medicine

Access to resources Recommend Favorite

Specificity of frontal dysfunctions in relapsing – remitting multiple sclerosis

By Santiago O.  

Archives of Clinical Neuropsychology, Vol. 22, Iss. 5, 2007-06 ,pp. : 623-629

Oxford University Press

Access to resources Recommend Favorite

Development of laquinimod for relapsing––remitting multiple sclerosis

By Jeffery Douglas R  

Future Neurology, Vol. 3, Iss. 6, 2008-11 ,pp. : 641-648

Future Medicine

Access to resources Recommend Favorite

Optical Coherence Tomography in Patients with Relapsing-Remitting Multiple Sclerosis without Optic Neuritis: A 20-Month Longitudinal Study

By Huseyinoglu Nergiz   Ozben Serkan   Ekinci Metin   Buyukuysal Cagatay   Yıldırım Murat   Safak Hilal   Huseyin Halil  

Neuro-Ophthalmology, Vol. 37, Iss. 3, 2013-06 ,pp. : 104-110

Informa Healthcare

Access to resources Recommend Favorite